ID: ALA172745

Max Phase: Preclinical

Molecular Formula: C10H12N2

Molecular Weight: 160.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1nc2c(C)c(C)ccc2[nH]1

Standard InChI:  InChI=1S/C10H12N2/c1-6-4-5-9-10(7(6)2)12-8(3)11-9/h4-5H,1-3H3,(H,11,12)

Standard InChI Key:  MQOSRBNWLNRDOU-UHFFFAOYSA-N

Associated Targets(non-human)

Cytochrome P450 2B1 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 160.22Molecular Weight (Monoisotopic): 160.1000AlogP: 2.49#Rotatable Bonds: 0
Polar Surface Area: 28.68Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.45CX Basic pKa: 7.05CX LogP: 2.41CX LogD: 2.26
Aromatic Rings: 2Heavy Atoms: 12QED Weighted: 0.63Np Likeness Score: -1.28

References

1. Murray M, Ryan AJ, Little PJ..  (1982)  Inhibition of rat hepatic microsomal aminopyrine N-demethylase activity by benzimidazole derivatives. Quantitative structure-activity relationships.,  25  (8): [PMID:7120277] [10.1021/jm00350a002]

Source